Occurrence of e antigen in acute hepatitis B

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Hepatitis B virus (HBV) infection can lead to chronic liver disease.
• The role of hepatitis B e antigen (HBeAg) in acute hepatitis B outcomes requires further clarification.

Purpose of the Study:

• To investigate the relationship between the presence of hepatitis B e antigen during acute infection and the development of the HBsAg carrier state.

Main Methods:

• Serum samples from 44 patients with acute hepatitis B were analyzed for the presence of e antigen.
• The development of the HBsAg carrier state was monitored in these patients.

Main Results:

• Hepatitis B e antigen was detected in 13.6% of acute cases, and none progressed to a carrier state.
• The HBsAg carrier state developed in 4.6% of patients, with no detectable e antigen in these individuals.
• Hepatitis B e antigen was primarily found in the early acute phase, highlighting the significance of sample timing.

Conclusions:

• The presence of hepatitis B e antigen during acute hepatitis B is associated with a reduced likelihood of developing a chronic carrier state.
• Early detection of e antigen may serve as a valuable prognostic marker for acute hepatitis B infection outcomes.